Table 4 Safety and mortality outcomes
Safety outcomes | N, (%) |
|---|---|
Major bleeding during procedure | 1 (0.67) |
Pulmonary artery injury during procedure | 0 (0) |
Cardiac tamponade during procedure | 0 (0) |
Clinical deterioration during the procedure | 4 (2.7) |
Cardiac arrest during the procedure with successful CPR | 1 (0.7) |
PE-related death during the procedure | 3 (2) |
Conversion to open surgery | 1 (0.7) |
Sustained ventricular tachycardia during the procedure | 0 (0) |
Sustained supraventricular tachycardia during the procedure | 1 (0.67) |
Procedure-related death | 3 (2) |
Major bleeding within 48 h post procedure | 2 (1.3) |
Hemorrhagic stroke | 1 (0.7) |
Pulmonary artery injury within 48 h post procedure | 0 (0) |
Cardiac tamponade within 48 h post procedure | 0 (0) |
Clinical deterioration within 48 h post procedure | 1 (0.7) |
PE-related death within 48 h post procedure | 0 (0) |
All-cause death within 48 h post procedure | 0 (0) |
Infection (pneumonia/sepsis) | 19 (12.7) |
Stroke (ischemic/hemorrhagic) | 0/1 (0/0.7) |
Sustained ventricular tachycardia within 48 h post procedure | 0 (0) |
Sustained supraventricular tachycardia within 48 h post procedure | 4 (2.7) |
PE- related mortality within 30 days post procedure | 0 (0) |
All-cause mortality within 30 days post-procedure | 0 (0) |
Major bleeding within 30 days post procedure | 0 (0) |
PE recurrence | 0 (0) |
PE- related mortality within 90 days post procedure | 0 (0) |
All-cause mortality within 90 days post procedure | 0 (0) |
PE recurrence | 0 (0) |
Major bleeding within 90 days post procedure | 0 (0) |